Stein Gold, L. .; Eyerich, K. .; Sofen, H. .; Herranz, P. .; Kircik, L. .; Bewley, T. .; Wolf, E. .; Gallo, G. .; Ding, Y. .; Yang, F. E. .; Pau-Charles, I. .; Gooderham, M. . Lebrikizumab Demonstrates Consistent Efficacy at 16 Weeks in Patients With Moderate-to-Severe Atopic Dermatitis Regardless of Baseline Disease Severity. J of Skin 2023, 7, s274.